Karyopharm Therapeutics reported $231.24M in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Amgen AMGN:US USD 63.7B 4.41B
AstraZeneca AZN:LN USD 94.18B 2.39B
Astrazeneca AZN:US USD 94.18B 2.39B
Avrobio Inc AVRO:US USD 129.5M 16.75M
Biocryst Pharmaceuticals BCRX:US USD 558.59M 48.06M
Bristol Myers Squibb BMY:US USD 98.2B 2.16B
Eli Lilly And LLY:US USD 47.46B 397.9M
Enanta Pharmaceuticals ENTA:US USD 375.41M 9.8M
GlaxoSmithKline GSK:LN GBP 60.31B 28.73B
Karyopharm Therapeutics KPTI:US USD 231.24M 25.24M
Macrogenics MGNX:US USD 195.35M 22.7M
Mirati Therapeutics MRTX:US USD 1.3B 23.29M
Nektar Therapeutics NKTR:US USD 781.01M 80.98M
Novartis NVS:US USD 118.46B 4.45B
Novartis NOVN:VX USD 118.46B 4.45B
Regeneron Pharmaceuticals REGN:US USD 27.68B 472M
Sangamo Biosciences SGMO:US USD 593.91M 23.21M
Takeda 4502:JP JPY 14.59T 523.42B
Tg Therapeutics TGTX:US USD 217.89M 33.78M
Ultragenyx Pharmaceutical RARE:US USD 1.62B 297.85M
Xencor XNCR:US USD 835.27M 16.06M
YTE INCY:US USD 5.51B 191.18M